<qa>  What is the primary objective of this study?The primary objective of this study is to determine the safety of transplantation of the patients own autologous Bone Marrow Progenitor Cells BMPC in children with SCI. The secondary objective is to determine if functional, physiological and anatomic outcome measures are improved after BMPC autologous transplantation in children with SCI. 